Optiver Holding
BEAM icon

Optiver Holding’s Beam Therapeutics BEAM Stock Holding History

Optiver Holding’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03K Sell
127
-85
-40% -$2.36K ﹤0.01% 1665
2025
Q4 		$5.88K Sell
212
-415
-66% -$10.6K ﹤0.01% 1293
2025
Q3 		$15.2K Buy
627
+298
+91% +$5.93K ﹤0.01% 1067
2025
Q2 		$5.6K Buy
329
+13
+4% +$226 ﹤0.01% 1165
2025
Q1 		$6.17K Buy
+316
New +$8.28K ﹤0.01% 1038

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Optiver Holding's BEAM Position: Q1 2026 in Review

Optiver Holding reduced its Beam Therapeutics (BEAM) stake by 40% in Q1 2026, selling an estimated $2.36K and leaving 127 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Optiver Holding first reported a position in BEAM in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.2K in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Optiver Holding held 127 shares of Beam Therapeutics worth $3.03K as of Q1 2026.
  • Optiver Holding sold 85 Beam Therapeutics shares in Q1 2026, an estimated $2.36K.
  • Beam Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1665 holding.
  • Optiver Holding first reported a position in Beam Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Optiver Holding's Beam Therapeutics position peaked at $15.2K in Q3 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.